Showing results (91-100 of 215) with videos related to

Sort By:
Pageof 22
Cardiovascular Research|November 17, 2007
Horizontal gene transfer from human endothelial cells to rat cardiomyocytes after intracoronary transplantationSandra Burghoff, Zhaoping Ding, Stefanie Gödecke, et al.
The Journal of Biological Chemistry|September 3, 2020
Replication stress at microsatellites causes DNA double-strand breaks and break-induced replicationRujuta Yashodhan Gadgil, Eric J Romer, Caitlin C Goodman, et al.
Science Translational Medicine|October 9, 2015
ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host diseaseJilu Zhang, Abdulraouf M Ramadan, Brad Griesenauer, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 2018
Influence of Stereochemistry on the Bioactivation and Glucuronidation of 4-IpomeanolAaron M Teitelbaum, Matthew G McDonald, John P Kowalski, et al.
Blood|January 9, 2009
Mesenchymal stem/progenitor cells promote the reconstitution of exogenous hematopoietic stem cells in Fancg-/- mice in vivoYan Li, Shi Chen, Jin Yuan, et al.
Human Gene Therapy|December 17, 2009
Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemiaAfrica González-Murillo, M Luz Lozano, Lara Alvarez, et al.
Blood|September 25, 2008
In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1Paula Río, Néstor W Meza, Africa González-Murillo, et al.
The Journal of Biological Chemistry|December 25, 2014
Protein-tyrosine phosphatase Shp2 positively regulates macrophage oxidative burstXing Jun Li, Charles B Goodwin, Sarah C Nabinger, et al.
Frontiers in Immunology|December 6, 2021
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-CellsCamilla M Grunewald, Corinna Haist, Carolin König, et al.
The Journal of Experimental Medicine|July 8, 2015
CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivoNicole Mende, Erika E Kuchen, Mathias Lesche, et al.
Pageof 22